- A novel intranasal antibody treatment shows potential in fighting tau protein buildup, which is a key factor in neurodegenerative diseases such as Alzheimer’s.
- A single dose of this treatment in aged mice with tau pathology significantly reduced tau accumulation and improved cognitive function.
- This approach could pave the way for new therapies targeting tau-related neurodegenerative conditions.
Scientists at the University of Texas Medical Branch have recently announced a novel method of…
Read the full article here